Literature DB >> 28627072

Reply to "Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanoma" by Mesbah Ardakani et al.

Amélie Boespflug1,2,3, Elisa Funck-Brentano4,5, Zofia Hélias-Rodzewicz5, Delphine Maucort-Boulch6,7, Alain Beauchet8, Pierre-Paul Bringuier9, Charles Dumontet2, Jean-François Emile5,6,7, Philippe Saiag4,5, Stéphane Dalle1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28627072     DOI： 10.1111/pcmr.12606

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  2 in total

1.  Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma.

Authors:  V Doma; S Kárpáti; E Rásó; T Barbai; J Tímár
Journal:  BMC Cancer       Date:  2019-08-07       Impact factor: 4.430

2.  Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancers.

Authors:  Priyanka Gopal; Elif Irem Sarihan; Eui Kyu Chie; Gwendolyn Kuzmishin; Semihcan Doken; Nathan A Pennell; Daniel P Raymond; Sudish C Murthy; Usman Ahmad; Siva Raja; Francisco Almeida; Sonali Sethi; Thomas R Gildea; Craig D Peacock; Drew J Adams; Mohamed E Abazeed
Journal:  Nat Commun       Date:  2019-11-13       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.